About Caramel CBDCarHybrid
The taste and aroma of CBD Caramel are all in the name; expect sweet and spicy flavors to hit the senses.
Dutch Bred, Indian Genetics, Afghani Genetics
CBD Caramel derives from the cross of a Brazilian, a Himalayan, an Afghan and an unknown CBD enriched cannabis strain. The result is just perfect for therapeutic use. With a 1:1 THC-CBD ratio, she is sure to please. The taste and aroma of CBD Caramel are all in the name; expect sweet and spicy flavors to hit the senses. Thanks to the balanced cannabinoid ratio, the psychoactive high delivered is pleasantly subtle and won't lock you into a body stone too heavily. It makes this cannabis strain well suited to both day and evening use, when you need to stay functional but want a nice buzz.
CBD Caramel is ideal for growing in humid climates but can do well just about anywhere that doesn't get too cold. She has a flowering time of 8-9 weeks indoors and can produce 450-550g/m² under ideal conditions. Outdoors, she is ready for harvest towards the end of September, usually producing around 450g/plant when treated just right.
Description provided by CannaConnection.
Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About Khiron Life Sciences Corp
Founded in October 2019, working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.
Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.
Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.
Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.khironmed.co.uk